ArticleJournal of burn care & research : official publication of the American Burn Association2022
Does Socioeconomic Status or Methamphetamine Use Affect Discharge Opioid Requirements in Burn-Injured Patients?
Article in Journal of burn care & research : official publication of the American Burn Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Methamphetamine (MA) use is associated with lower socioeconomic status (SES) and increased opioid use. Though MA use itself has been linked to larger burn injuries and increased length of stay, studies examining the effect of SES on opioid use in this patient population remain limited. The aim of this work was to examine how both SES and/or MA use in burn patients affected discharge opioid requirements. Records of burn patients admitted to an ABA-verified burn center were reviewed from January 2016 to December 2017. Patients were grouped into MA-positive (MPOS) or negative (MNEG) groups based on admission urine toxicology screening. Pain scores, oral morphine opioid equivalents (OEs), and adjunct pain medication use reported within 24 hours of discharge were examined. SES was determined by zip code. No difference was found between MPOS and MNEG groups regarding discharge OEs (P = .4), OE/TBSA (P = .79), or pain score (P = .09). Low SES was more prevalent in MPOS patients (P < .0001) but low SES was not a predictor of discharge OEs (P = .7), OE/TBSA (P = .7), or pain score (P = .15). Discharge OEs and OE/TBSA requirements correlated with discharge pain score (P < .0001) and LOS (P < .01), but not SES. Multivariate linear regression found that MNEG status (P = .005), pain score (P < .0001), concurrent use of benzodiazepines and gabapentin (P < .001), but not low SES, were independently associated with increased OEs. Although lower SES was seen in patients using MA, SES was not associated with discharge opioid use or pain scores. Additional work will be necessary to determine factors affecting opioid use in this population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.